Team:LZU-China/Project
From 2013.igem.org
(Difference between revisions)
(Prototype team page) |
Cancercell (Talk | contribs) |
||
(6 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
- | < | + | <html xmlns="http://www.w3.org/1999/xhtml"> |
+ | <head> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8" /> | ||
+ | <script src="http://code.jquery.com/jquery-1.10.1.min.js"></script> | ||
+ | <style type="text/css"> | ||
+ | /* main color : #ffb600 */ | ||
- | + | /**** alter igem default setting ***/ | |
- | + | #blank *{ width: 960px; border-style: none; margin: 0 auto; padding: 0; background-color: #000;} | |
- | + | #globalWrapper{ overflow: hidden; background-color: #000;} | |
- | + | #top,#header,h1.firstHeading,#catlinks{display: none;} | |
- | + | #content{width: 960px; background-attachment: scroll; overflow: hidden; border-style: none; background-color: #000;} | |
- | + | #footer-box{position:relative; z-index:100; background:none; border:none;} | |
- | + | #footer-box a{color:#FFF; font-size:13px;} | |
- | + | #footer #f-poweredbyico, #footer #f-copyrightico{display:none;} | |
- | + | #top-section{height:20px; border:none;} | |
- | + | #top-section #p-logo,#top-section .left-menu, #top-section #search-controls{display:none;} | |
- | + | #top-section .right-menu a{font-size:13px; font-weight:bold; color:#FFF; padding:2px 5px 2px 5px; background:none; text-decoration:none;} | |
- | + | #top-section .right-menu a:hover{color:#ffb600;} | |
- | + | #bodyContent h1, #bodyContent h2, #bodyContent h3{ margin-bottom:3px;} | |
- | + | body{height:100px;background-color:#000;} | |
+ | .body-in{margin:0 auto; overflow:auto; padding-bottom:50px; font-family:"微软雅黑", Arial; width:960px;} | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
+ | /** logo ***/ | ||
+ | .main-top .logo{background-image:url(https://static.igem.org/mediawiki/2013/b/bd/LZU-China_top.png); height:210px; background-repeat:no-repeat;} | ||
+ | .main-top .logo .op-box{display:none;} | ||
+ | .main-top .logo .op-box a{font-size:13px; padding:2px 5px 2px 5px; background-color:#FDD95B; color:#333; text-decoration:none; color:blue; margin-right:5px;} | ||
+ | .main-top .logo .op-box a:hover{text-decoration:underline;} | ||
+ | .main-top .logo:hover .op-box{display:block;} | ||
+ | /**** main items ****/ | ||
+ | ul.main-items{line-height:40px; overflow:auto; padding:0; margin-left:0;} | ||
+ | .main-items a{ text-decoration:none;} | ||
+ | .main-items li{ margin:0; padding:0;background-color:#ffb600; width:94px; color:#FFF; margin-left:3px; line-height:40px; float:left; padding:0 5px 0 5px; overflow:hidden;text-align:center; font-weight:bold; list-style-type:none; cursor:pointer;} | ||
+ | .main-items li.item1{ margin-left:0;} | ||
+ | .main-items li:hover, .main-items li.selected{ background-color:#555; color:#fff;} | ||
- | + | .main-center{overflow:auto; margin-top:30px; position:relative;} | |
+ | /***** left items******/ | ||
+ | .center-left{width:200px; color:#333; position:absolute; left:0; top:0;} | ||
+ | .center-left a{ text-decoration:none;} | ||
+ | .center-left h1,.center-left h2,.center-left h3{margin:0; cursor:pointer; padding:3px 0 3px 0; font-weight:normal; color:#FFF; border:1px solid #222; | ||
+ | margin-bottom:3px; background-repeat:no-repeat;} | ||
+ | .center-left h1:hover,.center-left h2:hover,.center-left h3:hover{ background-color:#ffb600;} | ||
+ | .center-left h1{ font-size:16px; padding-left:10px; line-height:36px;} | ||
+ | .center-left h2{ font-size:14px; padding-left:55px; line-height:28px; background-image:url(https://static.igem.org/mediawiki/2013/6/61/Layer_2_left_bg.png);} | ||
+ | .center-left h3{ font-size:13px; padding-left:95px; line-height:22px; background-image:url(https://static.igem.org/mediawiki/2013/0/07/Layer_3_left_bg.png);} | ||
- | |||
+ | .main-bottom{margin-top:80px; color:#FFF; text-align:center; font-size:13px; border-top:1px solid #666; padding-top:5px;} | ||
+ | .main-bottom a{color:#FFF;} | ||
+ | .main-bottom a:hover{color:#ffb600;} | ||
+ | /** main bg **/ | ||
+ | #main-bg-box {position: fixed;height:214px; width:100%; left:0px; text-indent:10px; bottom: 0px; background-image:url(https://static.igem.org/mediawiki/2013/7/7c/Main_bottom_bg.png); background-repeat:no-repeat; z-index:-1;} | ||
+ | * HTML #main-bg-box {position: absolute; bottom: auto; ; top: expression(eval(document.documentElement.scrollTop+document.documentElement.clientHeight-this.offsetHeight-(parseInt(this.currentStyle.marginTop,10)||0)-(parseInt(this.currentStyle.marginBottom,10)||0))-0); } | ||
+ | /*** right content ***/ | ||
+ | .center-right{width:680px; color:#FFF; float:right; padding:20px; min-height:400px; border:1px solid #333;} | ||
+ | /*** home page **/ | ||
+ | .main-center .home-items{ margin:0 auto; width:960px;} | ||
+ | .main-center .home-items a{ margin-left:76px; margin-top:30px; display:inline-block; border:none;} | ||
+ | .main-center .home-items a.item1{ margin-left:0;} | ||
+ | .main-center .home-items a.special{ margin-left:170px;} | ||
+ | .main-center .home-items a img{ width:260px; height:190px; border:none; margin:3px;} | ||
+ | .main-center .home-items a img:hover{ margin:0; border:3px solid #fff;} | ||
+ | /***** team page ****/ | ||
+ | .team{padding:10px; padding-top:30px;} | ||
+ | .team .one{border-bottom:2px solid #333; margin-bottom:30px; padding:0 20px 30px 20px;} | ||
+ | .team .one img{ width:240px; height:240px;} | ||
+ | .team .one .desc{ float:right; padding:15px; width:220px; height:150px; margin:30px 10px 0 0;width:300px; font-size:14px;} | ||
- | + | /***** notebook ****/ | |
+ | table{background:none;} | ||
+ | table td{color:#FFF; font-size:14px; padding-left:3px;} | ||
+ | h1,h2,h3,h4,h5,h6{color:#FFF;} | ||
+ | /*** center alone ***/ | ||
+ | .main-center .alone{border:1px solid #333; padding:20px; min-height:300px;} | ||
+ | </style> | ||
+ | <title>progect</title> | ||
+ | </head> | ||
+ | <body> | ||
- | === | + | <div class="body-in"> |
+ | <div class="main-top"> | ||
+ | <div class="logo"> | ||
+ | <div class="op-box"> | ||
+ | <a target="_self" href="https://2013.igem.org/wiki/index.php?title=Team:LZU-China/Project&action=edit">edit</a> | ||
+ | <a target="_self" href="https://2013.igem.org/Team:LZU-China/Team">view</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | <ul class="main-items"> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China"><li class="item1">Home</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Team"><li>Team</li></a> | ||
+ | <a href="https://igem.org/Team.cgi?year=2013&team_name=LZU-China"><li>Profile</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Project"><li class="selected">Project</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Parts"><li>Parts</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Notebook"><li>Notebook</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Safety"><li>Safety</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/Attributions"><li>Attributions</li></a> | ||
+ | <a href="https://2013.igem.org/Team:LZU-China/HumanPractice"><li>H.P.</li></a> | ||
+ | </ul> | ||
+ | </div> | ||
+ | |||
+ | <div class="main-center" id="main-center"> | ||
+ | <div class="center-left" id="center-left"> | ||
+ | <a href="#h-Design & Device"><h1>Design & Device</h1></a> | ||
+ | <a href="#h-Expriments"><h1>Expriments</h1></a> | ||
+ | |||
+ | </div> | ||
+ | |||
+ | <div class="center-right"> | ||
+ | |||
+ | <h2> <span class="mw-headline" id="h-Design & Device">Design & Device</span></h2> | ||
+ | <h3> <span class="mw-headline" id="Promoter">Promoter: 4 copies of NFκB gene </span></h3> | ||
+ | On the basis of NF-κB signaling pathway and its feedback loop dynamics, we provided a device: A high-throughput drug screening system. The system is used to screen targeted drugs in NF-κB signaling pathway and lasts even longer. Natrually, we could estimate whether the kind of drug is good or not. | ||
+ | <br><img src="https://static.igem.org/mediawiki/2013/6/64/LZU-China_Project_1.png"/> | ||
+ | <br><br>NF-κB is a DNA binding protein, which means that the dimer could recognize a certain gene sequence and bind with it. Thus, we designed a four coupies of NF-κB gene sequence as the promoter. The downstream gene IκB flag with GFP, which could be a controller in tumor invading,moreover , easy to observe. | ||
+ | </p> | ||
- | == | + | <h2> <span class="mw-headline" id="h-Expriments">Expriments</span></h2> |
+ | 4X-NFκB-IκBα-4.20 was tranfected in DU145 cells, Hep-G2, Changliver cells. Since the these kinds of cells have background expression of NF-κB, we use gene knockout technology to remove these parts of gene. | ||
+ | These images were taken with a cooled CCD camera 1 day after transfection using the fluorescent microscope. The images all showed that our promoter 4X-NFκB responsed in a good condition by that time, and the difference of brightness of the fluorescent also provide a evidence that our recombainat vector works well. | ||
+ | Additionally, we will do some experiments to transfect DU145, 293T and Hela cells with the vector for establishment of stable cell lines for further research. | ||
+ | <br><img src="https://static.igem.org/mediawiki/2013/f/f7/Initpintu_LZU.jpg"/> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div class="main-bottom"> | ||
+ | LanZhou University | 222 TianShui South Road, ChengGuan District, LanZhou, China, 730000<br> | ||
+ | E-mail:hwang2013@lzu.edu.cn<br> | ||
+ | LanZhou University © 2013 <a target="_new" href="http://en.lzu.edu.cn">Privacy Policy</a> | ||
+ | </div> | ||
+ | </div> | ||
+ | <div id="main-bg-box"> </div> | ||
+ | |||
+ | </body> | ||
- | + | <script type="text/javascript"> | |
- | + | (function(){ | |
- | === | + | var deal = { |
- | + | setItemPos : function(e){ | |
- | + | var sc = $(document).scrollTop(); | |
- | + | var space = sc - e.parent().offset().top; | |
- | + | e.css({top: (space<0? 0 : space) +'px'}); | |
- | = | + | } |
+ | } | ||
+ | window.onscroll = function(){deal.setItemPos($("#center-left"));} | ||
+ | } | ||
+ | )(); | ||
+ | </script> | ||
+ | </html> |
Latest revision as of 04:01, 28 September 2013
Design & Device
Promoter: 4 copies of NFκB gene
On the basis of NF-κB signaling pathway and its feedback loop dynamics, we provided a device: A high-throughput drug screening system. The system is used to screen targeted drugs in NF-κB signaling pathway and lasts even longer. Natrually, we could estimate whether the kind of drug is good or not.NF-κB is a DNA binding protein, which means that the dimer could recognize a certain gene sequence and bind with it. Thus, we designed a four coupies of NF-κB gene sequence as the promoter. The downstream gene IκB flag with GFP, which could be a controller in tumor invading,moreover , easy to observe.
Expriments
4X-NFκB-IκBα-4.20 was tranfected in DU145 cells, Hep-G2, Changliver cells. Since the these kinds of cells have background expression of NF-κB, we use gene knockout technology to remove these parts of gene. These images were taken with a cooled CCD camera 1 day after transfection using the fluorescent microscope. The images all showed that our promoter 4X-NFκB responsed in a good condition by that time, and the difference of brightness of the fluorescent also provide a evidence that our recombainat vector works well. Additionally, we will do some experiments to transfect DU145, 293T and Hela cells with the vector for establishment of stable cell lines for further research.
LanZhou University | 222 TianShui South Road, ChengGuan District, LanZhou, China, 730000
E-mail:hwang2013@lzu.edu.cn
LanZhou University © 2013 Privacy Policy
E-mail:hwang2013@lzu.edu.cn
LanZhou University © 2013 Privacy Policy